A polymorphism in the growth hormone-releasing hormone receptor gene: Clinical significance?

Regulatory Peptides

Volumn 108, Issue 2-3, 2002, Pages 125-128

  Adams, Eric F ^a   Oikonomou, Eftychia ^a   Bhamrah, Mandeep ^a   Buchfelder, Michael ^b   Mitchell, Rosalind ^c   Poyner, David R ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Acromegaly; Growth hormone releasing hormone receptor gene; Polymorphism

Indexed keywords

ALANINE; AMINO ACID; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; GROWTH HORMONE RELEASING FACTOR; THREONINE;

ACROMEGALY; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; GROWTH HORMONE BLOOD LEVEL; HOMOZYGOSITY; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS TUMOR; IN VITRO STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEPTOR GENE; RISK; SOMATOTROPHINOMA;

EID: 0037107397     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(02)00101-5     Document Type: Article

References (14)

1. Melmed S. Medical management of acromegaly - what and when? Acta Endocrinol. (Copenh.). 129(Suppl. 1):1993;13-17.
2. Klibanski A. Further evidence for somatic mutation theory in the pathogenesis of human pituitary tumors. J. Clin. Endocrinol. Metab. 71:1990;1415A-1415C.
3. s and stimulate adenylyl cyclase in human pituitary tumours. Nature. 340:1989;692-696.
4. s and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature. 330:1987;198-203.
5. Petersenn S., Scheinder-Merck T., Beil F.U., Luedecke D.K., Schulte H.M. Activating mutations of the growth hormone-releasing hormone receptor in somatotrophic pituitary adenomas. Exp. Clin. Endocrinol. Diabetes. 108(Suppl. 1):2000;S4.
6. Adams E.F., Symowski H., Buchfelder M., Poyner D.R. A polymorphism in the growth hormone (GH)-releasing hormone (GHRH) receptor gene is associated with elevated response to GHRH by human pituitary somatotrophinomas in vitro. Biochem. Biophys. Res. Commun. 275:2000;33-36.
7. Mayo K.E., Hammer R.E., Swanson L.W., Vale W. Dramatic pituitary hyperplasia in transgenic mice expressing a growth hormone-releasing factor gene. Mol. Endocrinol. 2:1985;606-612.
8. Adams E.F., Lei T., Buchfelder M., Petersen B., Fahlbusch R. Biochemical characteristics of human pituitary somatotrophinomas with and without gsp mutations: in vitro cell culture studies. J. Clin. Endocrinol. Metab. 80:1995;2077-2081.
9. Mayo K.E., Godfrey P.A., Suhr S.T., Kulik D.J., Rahal J.O. Growth hormone-releasing hormone: synthesis and signaling. Recent Prog. Horm. Res. 50:1995;35-73.
10. Burton F.H., Hasel K.W., Bloom F.E., Sutcliffe J.G. Pituitary hyperplasia and gigantism in mice caused by a cholers toxin transgene. Nature. 350:1991;74-77.
11. Spiegel A.M. Mutations in G protein-coupled receptors in endocrine disease. J. Clin. Endocrinol. Metab. 81:1996;2434-2442.
12. Wood S.M., Ch'ng J.L.C., Adams E.F., Webster J.D., Joplin G.F., Mashiter K.et al. Abnormalities of growth hormone release to human pancreatic growth hormone releasing factor (GRF(1-44)) in acromegaly and hypopituitarism. Br. Med. J. 286:1983;1687.
13. Chan K.W., Yu K.L., Rivier J., Chow B.K. Identification and characterization of a receptor from goldfish specific for a teleost growth hormoine-releasing hormone-like peptide. Neuroendocrinology. 68:1998;44-56.
14. Hasmar A.J. Family-B G-protein coupled receptors. Genome Biol. 2:2001;3013.1-3013.10.